Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference51 articles.
1. Cancer of the ovary;Cannistra;N. Engl. J. Med.,2004
2. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells;Andrews;Cancer Res.,1988
3. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation;Parker;J. Clin. Invest.,1991
4. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis;Godwin;Proc. Natl. Acad. Sci. U. S. A.,1992
5. Overexpression of metallothionein confers resistance to anticancer drugs;Kelley;Science,1988
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels;Molecular Oncology;2021-07-13
2. Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies;Overcoming Drug Resistance in Gynecologic Cancers;2021
3. Drug resistance in gynecologic cancers: Findings and underlying mechanisms;Overcoming Drug Resistance in Gynecologic Cancers;2021
4. The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication;International Journal of Molecular Sciences;2020-11-30
5. Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images;Diagnostics;2020-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3